Company Filing History:
Years Active: 2001-2009
Title: Thomas M Laz: Innovator in Histamine Receptor Research
Introduction
Thomas M Laz is a notable inventor based in Parlin, NJ (US), recognized for his contributions to the field of biochemistry and pharmacology. He holds a total of 11 patents, showcasing his innovative work in receptor research and therapeutic applications.
Latest Patents
Among his latest patents, one significant invention involves the development of an isolated mammalian histamine receptor. This invention provides isolated or recombinant nucleic acids and recombinant vectors encoding the receptor, as well as host cells that comprise these nucleic acids and vectors. The invention also includes antibodies and antigen-binding fragments that specifically bind to the receptor, which are useful for treating medical conditions caused or mediated by histamine. Additionally, it offers screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor. Another notable patent focuses on methods of identifying melanin concentrating hormone receptor antagonists. This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, and vectors comprising the isolated nucleic acid. It also includes methods for isolating the receptor and treating abnormalities linked to its activity.
Career Highlights
Throughout his career, Thomas M Laz has worked with prominent companies such as Schering Corporation and Synaptic Pharmaceutical Corporation. His work in these organizations has significantly contributed to advancements in pharmaceutical research and development.
Collaborations
Thomas has collaborated with notable individuals in his field, including Suke Wang and John A Salon. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Thomas M Laz is a distinguished inventor whose work in histamine receptor research has led to significant advancements in medical treatments. His numerous patents reflect his dedication to innovation and the betterment of healthcare solutions.